APOA1作为一个潜在的治疗标和在肺腺癌中的新生物标记物
Yuening Sun1, Jie Shen2, Yizhou Lin3
1Department of Pharmacy, Affiliated Hospital of Nantong University, Pharmacy School of Nantong University, Nantong, China.
Cell biochemistry and function
|November 24, 2025
概括
阿波利波蛋白A1 (APOA1) 在肺腺癌 (LUAD) 中降低调节,作为瘤抑制剂. 血清APOA1水平降低可能有助于早期检测LUAD并指导治疗策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 脂蛋白A1 (APOA1) 是一种高密度脂蛋白蛋白,在癌症中具有已知但不清楚的作用.
- 它在肺腺癌 (LUAD) 中的特定功能需要全面调查.
研究的目的:
- 使用集成的多omics数据阐明APOA1在LUAD中的作用.
- 验证APOA1作为潜在的诊断生物标志物和LUAD治疗点.
主要方法:
- 对APOA1表达,变化和免疫透的公共多组数据集 (TCGA,HPA,UALCAN,cBioPortal) 的分析.
- 在LUAD患者和健康对照中量化血清APOA1水平.
- 在体外和体外功能测试以评估APOA1对LUAD细胞行为和瘤生长的影响.
- 与药物敏感性和免疫细胞透的相关性分析.
主要成果:
- 在LUAD中,APOA1显著下调,与患者存活率较差相关.
- 血清APOA1水平降低表明LUAD的诊断准确度很高 (AUC=0.942).
- 过度表达APOA1抑制了LUAD细胞的增殖,迁移,入侵和瘤生长 in vivo.
- 高APOA1表达与补充/凝血通路和特定的免疫透模式有关.
- APOA1状态预测对某些药物的敏感性增加,例如塞卢美替尼布.
结论:
- 在LUAD中,APOA1作为瘤抑制剂起作用.
- APOA1是早期检测LUAD和患者分层的一个有前途的生物标志物.
- 准APOA1可能为LUAD提供新的治疗和免疫调节策略.
关键词:
在 APOA1A1 中,APOA1A1是APOA1A.卢阿德·卢阿德 (LUAD LUAD) 是一个古老的城市.生物信息学是一种生物信息学.移民 移民 迁移 迁移它们的扩散和扩散.幸存率 幸存率 生存率更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
18.1K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.7K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K